Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A malignant neoplasm arising from mesothelial cells in the pleura. It is characterized by the presence of neoplastic epithelioid cells and sarcomatoid features.
Biomarker and diagnostic research for malignant biphasic mesothelioma has been reported in the published literature.
3 clinical trials registered, 1 recruiting. Interventions under study include procedural interventions, drug therapy, and biologic therapy. Pipeline includes 2 PHASE2, 1 PHASE1. Research is primarily sponsored by academic and government institutions.
48 publications have been identified in PubMed for malignant biphasic mesothelioma. Research spans Basic Science / Preclinical (27%), Case Report / Case Series (25%), and Diagnostic / Biomarker (15%).
Research Type | Count | % of Total |
|---|---|---|
Laboratory research | 13 |
Data assembled from 3 of 12 sources · Last updated Sep 19, 2026, 11:54 AM UTC
27%
Patient case studies | 12 | 25% |
Testing and diagnosis research | 7 | 15% |
Clinical study results | 7 | 15% |
Disease patterns and progression | 5 | 10% |
Research summaries | 3 | 6% |
New treatment approaches | 1 | 2% |
Findley J (2026). [PMID: 41721215](https://pubmed.ncbi.nlm.nih.gov/41721215/). *Cytopathology : official journal of the British Society for Clinical Cytology*. [Basic Science / Preclinical]
Çakılkaya P (2026). [PMID: 41366685](https://pubmed.ncbi.nlm.nih.gov/41366685/). *Cancer research communications*. [Basic Science / Preclinical]
Sato H (2026). [PMID: 41952749](https://pubmed.ncbi.nlm.nih.gov/41952749/). *Surg Neurol Int*. [Case Report / Case Series]
An Q (2026). [PMID: 41655170](https://pubmed.ncbi.nlm.nih.gov/41655170/). *Discover oncology*. [Diagnostic / Biomarker]
Al Achkar Z (2026). [PMID: 42026555](https://pubmed.ncbi.nlm.nih.gov/42026555/). *BMC Pulm Med*. [Review / Meta-Analysis]
Gagnon MF (2026). [PMID: 41967647](https://pubmed.ncbi.nlm.nih.gov/41967647/). *Hum Pathol*. [Basic Science / Preclinical]
Zhao T (2026). [PMID: 42237856](https://pubmed.ncbi.nlm.nih.gov/42237856/). *Int J Surg Pathol*. [Case Report / Case Series]
Gong Q (2026). [PMID: 41711168](https://pubmed.ncbi.nlm.nih.gov/41711168/). *Genes, chromosomes & cancer*. [Review / Meta-Analysis]
Alves de Lima A (2026). [PMID: 41490976](https://pubmed.ncbi.nlm.nih.gov/41490976/). *The American journal of cardiology*. [Basic Science / Preclinical]
Janssens E (2026). [PMID: 41534436](https://pubmed.ncbi.nlm.nih.gov/41534436/). *Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie*. [Diagnostic / Biomarker]
AI-curated news mentioning malignant biphasic mesothelioma
Updated May 1, 2026
A study reports on the genetic and immunohistochemical profiling of malignant mesothelioma with brain metastasis in two cases. This research contributes to understanding the molecular characteristics of this aggressive cancer.
A recent case report details malignant mesothelioma of the tunica vaginalis testis, contributing to the understanding of this rare cancer. This case highlights the need for further research into its etiology and treatment options.